Immunogenicity of HPV Quadrivalent Vaccine in Women After Allogeneic HCT Is Comparable to Healthy Volunteers

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.12.656
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Quadrivalent HPV Vaccine in Argentina: Cost-Effectiveness Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine

Drugs
Pharmacology
2011English

HPV Vaccine Uptake After Introduction of the Vaccine in Germany

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2014English

Evaluation of Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2015English

HPV Vaccine Highly Effective in Uninfected Young Women

BMJ
2007English

Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted With MF59 Administered to Healthy Adults

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2010English

Antibody Persistence After a Single Dose of Quadrivalent HPV Vaccine and the Effect of a Dose of Nonavalent Vaccine Given 3-8 Years Later – An Exploratory Study

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males

Drugs in R and D
Pharmacology
2012English

Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy